Cleared Traditional

K103103 - PRESSON ELECTRODE

K103103 is an FDA 510(k) clearance for PRESSON ELECTRODE, manufactured by Persyst Development Corp.. The device is a Class 2 Neurology device with product code GXZ cleared through the Traditional 510(k) pathway after a 414-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
414d
Days
Class 2
Risk

K103103 is an FDA 510(k) clearance for the PRESSON ELECTRODE. Classified as Electrode, Needle (product code GXZ), Class II - Special Controls.

Submitted by Persyst Development Corp. (Prescott, US). The FDA issued a Cleared decision on December 8, 2011 after a review of 414 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1350 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Persyst Development Corp. devices

FDA 510(k) Submission Details - K103103

510(k) Number K103103 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 20, 2010
Decision Date December 08, 2011
Days to Decision 414 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
266d slower than avg
Panel avg: 148d · This submission: 414d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXZ Device Classification - Class 2, Special Controls

Product Code GXZ Electrode, Needle
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1350
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXZ Electrode, Needle

All 23
Devices cleared under the same product code (GXZ) and FDA review panel - the closest regulatory comparables to K103103.
PressOn Electrode Headset
K190801 · Rhythmlink International, LLC · Jul 2019
MR CONDITIONAL PRESSON ELECTRODE
K130220 · Rhythmlink International, LLC · Jul 2013
PRESSON ELECTRODE
K121347 · Rhythmlink International, LLC · Jul 2012
AVS ARIA NEUROMONITORING PROBE AND AVS ARIA PROBE DILATORS
K110419 · Stryker Spine · Jul 2011
DISPOSABLE NERVE STIMULATING PROBE, BIPOLAR CONCENTRIC, DISPOSABLE NERVE STIMULATOR PROBE, BIPOLAR SIDE BY SIDE
K100912 · Kirwan Surgical Products, Inc. · Aug 2010
NERVE MONITORING CABLE
K073229 · Pioneer Surgical Technology · Jun 2008